Type 2 diabetes mellitus - Greater cardiovascular risks and greater benefits of therapy

被引：46
作者：
Fagan, TC
Sowers, J
机构：
[1] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85750 USA
[2] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85750 USA
[3] Wayne State Univ, Dept Med, Detroit, MI 48201 USA
[4] Wayne State Univ, Dept Physiol, Detroit, MI 48201 USA
来源：
ARCHIVES OF INTERNAL MEDICINE | 1999年 / 159卷 / 10期
关键词：
D O I：
10.1001/archinte.159.10.1033
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1033 / 1034
页数：2
相关论文
共 50 条
  • [31] Decoding cardiovascular risks: analyzing type 2 diabetes mellitus and ASCVD gene expression
    Zhang, Youqi
    Ji, Liu
    Yang, Daiwei
    Wu, Jianjun
    Yang, Fan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [32] Bariatric surgery in Medicare patients: greater risks but substantial benefits
    Yuan, Xiang
    Hawver, Lisa. R. Martin
    OJo, Peter
    Wolfe, Luke A.
    Meador, Jill G.
    Kellum, John M.
    Maher, James W.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2009, 5 (03) : 299 - 304
  • [33] Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus
    Betteridge, J
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 : 10S - 15S
  • [34] THE PREVALANCE OF DIABETES-MELLITUS IN THE GREATER ATHENS AREA
    DIAMANTOPOULOS, EJ
    RAPTIS, S
    NANAS, S
    MOULOPOULOS, S
    DIABETOLOGIA, 1986, 29 (08) : A533 - A533
  • [35] Cardiovascular Therapy Benefits of Novel Antidiabetic Drugs in Patients With Type 2 Diabetes Mellitus Complicated With Cardiovascular Disease: A Network Meta-Analysis
    Shi, Saixian
    Li, Xiaofeng
    Chen, Ye
    Li, Jiahao
    Dai, Yan
    JOURNAL OF DIABETES, 2025, 17 (01)
  • [36] Cardiovascular risk in type 2 diabetes mellitus
    Hohberg, C.
    Roth, W.
    Luebben, G.
    Forst, T.
    Gauert, S.
    Karagiannis, F.
    Reimer, T.
    Gottschall, V.
    Pfuetzner, A.
    DIABETES STOFFWECHSEL UND HERZ, 2007, 16 (03): : 173 - 177
  • [37] Type 2 diabetes mellitus: a cardiovascular perspective
    Varughese, GI
    Tomson, J
    Lip, GYH
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (07) : 798 - 816
  • [38] Cardiovascular risks in type 2 diabetes and secondary cardiovascular prevention
    Ducimetière, P
    DIABETES & METABOLISM, 2005, 31 (05) : 503 - 506
  • [39] Therapy of diabetes mellitus type 2
    Wiegand, S
    MONATSSCHRIFT KINDERHEILKUNDE, 2005, 153 (10) : 936 - +
  • [40] Balancing the risks and benefits for pioglitazone in type 2 diabetes
    Johnson, Jeffrey A.
    Colmers, Isabelle N.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 98 (01) : 1 - 2
12345